Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ingeborg Stalmans, Yin-Shan Ng, Richard Rohan, Marcus Fruttiger, Ann Bouché, Ali Ÿuce, Hajime Fujisawa, Bart Hermans, Moshe Shani, Sandra Jansen, Dan Hicklin, David J. Anderson, Tom Gardiner, Hans-Peter Hammes, Lieve Moons, Mieke Dewerchin, Désiré Collen, Peter Carmeliet, Patricia A. D’Amore
Published in Volume 109, Issue 3
J Clin Invest. 2002; 109(3):327–336 doi:10.1172/JCI14362
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

VEGF receptor expression in VEGF+/+ retinas. (a) Whole-mount in situ hybridization for NP-1 at P5. Expression is prominent in arterioles and discrete in venules. (b) In situ hybridization on retinal sections at P7 is suggestive of NP-1 expression in ECs as well as PECs (arrows). (c and d) High magnification of whole-mount in situ hybridization for (c) NP-1 and (d) PDGF receptor-β (PDGFRβ) illustrates that PECs are positive for PDGFRβ and suggest NP-1 expression in PECs (arrows). (e and j) Fluorescent triple immunostaining using lectin, anti-SMA, and anti-VEGFR on sections from VEGF+/+ eyes at P9. Lectin (blue), VEGFR (red), and SMA (green). (e and f) NP-1 is detectable in retinal neurons (arrowheads), but its expression is beyond the detection limit in vessels by immunostaining. (g and h) VEGFR-1 (R1) is expressed in vSMCs as well as ECs (arrow). (i and j) VEGFR-2 (R2) expression is only detectable in the ECs (arrows) in capillaries and venules.